Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers?
- PMID: 23929926
- PMCID: PMC3789348
- DOI: 10.2215/CJN.07370713
Aldosterone breakthrough during angiotensin receptor blocker use: more questions than answers?
Comment on
-
Determinants and changes associated with aldosterone breakthrough after angiotensin II receptor blockade in patients with type 2 diabetes with overt nephropathy.Clin J Am Soc Nephrol. 2013 Oct;8(10):1694-701. doi: 10.2215/CJN.06960712. Epub 2013 Aug 8. Clin J Am Soc Nephrol. 2013. PMID: 23929924 Free PMC article. Clinical Trial.
References
-
- Bakris G, Burgess E, Weir M, Davidai G, Koval S; AMADEO Study Investigators: Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy. Kidney Int 74: 364–369, 2008 - PubMed
-
- Williams GH, Braley LM: Effects of dietary sodium and potassium intake and acute stimulation on aldosterone output by isolated human adrenal cells. J Clin Endocrinol Metab 45: 55–64, 1977 - PubMed
-
- Remuzzi G, Cattaneo D, Perico N: The aggravating mechanisms of aldosterone on kidney fibrosis. J Am Soc Nephrol 19: 1459–1462, 2008 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
